abiraterone,docetaxel
Not Tagged
['prostate', 'crpc', 'gu ', 'peace-1', 'novo ']
peace-1: prostate xrt in lv, de novo mhspc rpfs benefits only in pts receiving abi+soc (adt+/-doce): median: 7.5 vs 4.4 yrs no os benefit w/ xrt addition to abi+soc or soc only arms time to crpc &amp; time to serious gu events in both lv &amp; overall cohorts #asco23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @MCG_Urology and @AUB_Lebanon 🇱🇧